Table 1.
Summary of the 17 binary classification datasets used in this study
| ID | Dataset | Samples | Features | Summary |
|---|---|---|---|---|
| 1 | DLBCL | 77 | 7129 | DLBCL patients (58) and follicular lymphoma (19) |
| 2 | Pros (Prostate) | 102 | 12625 | prostate (52) and non-prostate (50) |
| 3 | Colon | 62 | 2000 | tumour (40) and normal (22) |
| 4 | Leuk (Leukaemia) | 72 | 7129 | ALL (47) and AML (25) |
| 5 | Mye (Myeloma) | 173 | 12625 | presence (137) and absence (36) of focallesions of bone |
| 6 | ALL1 | 128 | 12625 | B-cell (95) and T-cell (33) |
| 7 | ALL2 | 100 | 12625 | Patients that did (65) and did not (35) relapse |
| 8 | ALL3 | 125 | 12625 | with (24) and without (101) multidrug resistance |
| 9 | ALL4 | 93 | 12625 | with (26) and without (67) the t(9;22) chromosome translocation |
| 10 | CNS | 60 | 7129 | medulloblastoma survivors (39) and treatment failures (21) |
| 11 | Lym (Lymphoma) | 45 | 4026 | germinalcentre (22) and activated B-like DLBCL (23) |
| 12 | Adeno (Adenoma) | 36 | 7457 | colon adenocarcinoma (18) and normal (18) |
| 13 | Gas (Gastric) | 65 | 22645 | tumors (29) and non-malignants (36) |
| 14 | Gas1 (Gastric1) | 144 | 22283 | non-cardia (72) of gastric and normal (72) |
| 15 | Gas2 (Gastric2) | 124 | 22283 | cardia (62) of gastric and normal (62) |
| 16 | T1D | 101 | 54675 | T1D (57) and healthy control (44) |
| 17 | Stroke | 40 | 54675 | ischemic stroke (20) and control (20) |
Column “Dataset” gives the dataset names that will be used throughout this manuscript. Columns “Samples” and “Features” are the numbers of samples and features in this dataset, respectively. Column “Summary” describes the two sample classes, and the sample number in each class is given in the parenthesis. Details of the dataset and the original study may be found in the references listed in the column “Reference”